MEIRAGTX HLDGS PLC's ticker is MGTX and the CUSIP is G59665102. A total of 106 filers reported holding MEIRAGTX HLDGS PLC in Q2 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $90 | -19.6% | 18,000 | 0.0% | 0.00% | – |
| Q4 2022 | $112 | -99.9% | 18,000 | 0.0% | 0.00% | – |
| Q3 2022 | $145,000 | +8.2% | 18,000 | 0.0% | 0.00% | – |
| Q2 2022 | $134,000 | -46.8% | 18,000 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $252,000 | -34.2% | 18,000 | +9.8% | 0.00% | 0.0% |
| Q4 2021 | $383,000 | +91.5% | 16,400 | +2.5% | 0.00% | 0.0% |
| Q3 2021 | $200,000 | -19.0% | 16,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $247,000 | +13.3% | 16,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $218,000 | -11.4% | 16,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $246,000 | +18.3% | 16,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $208,000 | – | 16,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 2,898,550 | $38,957,000 | 21.20% |
| Prosight Management, LP | 568,348 | $7,639,000 | 3.57% |
| Perceptive Advisors | 6,433,277 | $86,463,000 | 2.25% |
| Orbimed Advisors | 3,582,320 | $48,146,000 | 0.81% |
| Parkman Healthcare Partners LLC | 125,000 | $1,680,000 | 0.78% |
| 683 Capital Management, LLC | 831,748 | $11,178,000 | 0.66% |
| Claraphi Advisory Network, LLC | 98,850 | $1,329,000 | 0.63% |
| Fort Sheridan Advisors LLC | 54,512 | $733,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 246,307 | $3,310,000 | 0.46% |
| PA Capital LLC | 39,039 | $525,000 | 0.46% |